In the News
Aardvark Therapeutics has been featured in numerous online resources and media sites.
Series C financing led by Decheng Capital and supported by a syndicate of new and existing investors including Cormorant Asset...
A link to the full article by STAT can be found here.
...
The FDA granted Aardvark Therapeutics a Rare Pediatric Designation for the use of ARD-101 in Prader-Willi Syndrome (PWS), a rare...
Click here to view the full article (external link)
...